RECOMBINANT INTERLEUKIN-12, A BROAD-SPECTRUM BIOLOGIC FOR THE TREATMENT OF BATTLE AND TRAUMATIC WOUND INFECTIONS
$2,354,053FY2015Department of the ArmyDOD
Neumedicines Inc.
Investigators
View source on USAspending →RECOMBINANT INTERLEUKIN-12, A BROAD-SPECTRUM BIOLOGIC FOR THE TREATMENT OF BATTLE AND TRAUMATIC WOUND INFECTIONS · GrantIndex